| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1111514227 |
| P356 | DOI | 10.1186/S13099-018-0281-6 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s13099-018-0281-6 |
| P932 | PMC publication ID | 6337822 |
| P698 | PubMed publication ID | 30675188 |
| P2093 | author name string | Jian Xu | |
| Fan Li | |||
| Jianwei Wang | |||
| Xuhua Mao | |||
| Xingyin Liu | |||
| Yewei Zhang | |||
| Qisha Liu | |||
| Yaoyao Zhuang | |||
| P2860 | cites work | Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 |
| Regulation of immune cell function by short-chain fatty acids | Q26748416 | ||
| Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development | Q26851211 | ||
| Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription | Q28567399 | ||
| The fermentation pathways of Escherichia coli | Q29543129 | ||
| Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients | Q29614261 | ||
| Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences | Q29615050 | ||
| Microbiota and SCFA in lean and overweight healthy subjects | Q29615812 | ||
| Epidemiology of viral hepatitis and hepatocellular carcinoma | Q29617918 | ||
| Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease | Q33981675 | ||
| Functional gene arrays-based analysis of fecal microbiomes in patients with liver cirrhosis. | Q34227211 | ||
| Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures | Q34302587 | ||
| The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. | Q51736365 | ||
| Towards ending viral hepatitis as a public health threat: translating new momentum into concrete results in South-East Asia. | Q52668291 | ||
| The gut microbiota influences anticancer immunosurveillance and general health. | Q52720203 | ||
| Characterization of fecal microbial communities in patients with liver cirrhosis. | Q54372904 | ||
| The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome | Q59796444 | ||
| The gut-liver axis and the intersection with the microbiome | Q88634168 | ||
| Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma | Q90473607 | ||
| Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis | Q93017954 | ||
| Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liver | Q34405039 | ||
| Immune system stimulation by probiotic microorganisms | Q34659496 | ||
| Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease | Q35040827 | ||
| Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach | Q35076295 | ||
| Altered profile of human gut microbiome is associated with cirrhosis and its complications | Q35077209 | ||
| Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas | Q35112364 | ||
| Alterations of the human gut microbiome in liver cirrhosis | Q35216354 | ||
| Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy | Q35833912 | ||
| The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota | Q35850620 | ||
| Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases | Q35862775 | ||
| Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. | Q36074799 | ||
| Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation | Q36309525 | ||
| CAR-T cell therapy in gastrointestinal tumors and hepatic carcinoma: From bench to bedside | Q37559401 | ||
| Alpha fetoprotein is more than a hepatocellular cancer biomarker: from spontaneous immune response in cancer patients to the development of an AFP-based cancer vaccine | Q37894804 | ||
| Interactions between the intestinal microbiome and liver diseases | Q38179779 | ||
| HBV and the immune response | Q38295864 | ||
| Systemic and Splanchnic Lipopolysaccharide and Endothelin-1 Plasma Levels in Liver Cirrhosis before and after Transjugular Intrahepatic Portosystemic Shunt | Q38418029 | ||
| Gut Microbiota of Nonalcoholic Fatty Liver Disease | Q38742769 | ||
| Gut microbiome and liver disease | Q38914215 | ||
| Development of T cells redirected to glypican-3 for the treatment of hepatocellular carcinoma | Q38947320 | ||
| The gut microbiome and liver cancer: mechanisms and clinical translation. | Q39414187 | ||
| A heuristic graph comparison algorithm and its application to detect functionally related enzyme clusters | Q39584601 | ||
| Cancer statistics in China, 2015. | Q40064386 | ||
| Mechanisms of Hepatitis B Virus Persistence | Q40077350 | ||
| The Impact of the Hepatitis B Core Antibody Status on Recurrence in Patients with Non-B Non-C Hepatocellular Carcinoma after Curative Surgery | Q40082429 | ||
| Stapler Transection of the Oesophagus for Bleeding Oesophageal Varices | Q40171353 | ||
| Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step | Q41706834 | ||
| Toll like receptor7 polymorphisms in relation to disease susceptibility and progression in Chinese patients with chronic HBV infection | Q41927571 | ||
| Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts | Q42091545 | ||
| The role of the gut microbiota in nonalcoholic fatty liver disease | Q42838234 | ||
| Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients | Q44319592 | ||
| Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients | Q47098813 | ||
| Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. | Q47447695 | ||
| Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease. | Q48105576 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| WGCNA | Q102537983 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 1 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Gut Pathogens | Q15817917 |
| P1476 | title | Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma | |
| P478 | volume | 11 |
| Q90862879 | Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome |
| Q93199879 | Interaction of the microbiota with the human body in health and diseases |
| Q97885906 | Long-Term Exposure to Ceftriaxone Sodium Induces Alteration of Gut Microbiota Accompanied by Abnormal Behaviors in Mice |
| Q92759091 | Multiple "Omics" data-based biomarker screening for hepatocellular carcinoma diagnosis |
| Q93070050 | Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma |
| Q91796502 | Role of Gut Microbiota in Hepatocarcinogenesis |
| Q98771307 | Role of Microbiota in Pathogenesis and Management of Viral Hepatitis |
| Q91584430 | The intestinal microbial community dissimilarity in hepatitis B virus-related liver cirrhosis patients with and without at alcohol consumption |
Search more.